Paragon 28, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FNA research report →
About the company
Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions.
- CEO
- Albert DaCosta
- IPO
- 2021
- Employees
- 525
- HQ
- Englewood, CO, US
Price Chart
- Market Cap
- $1.10B
- P/E
- -19.83
- P/S
- 4.29
- P/B
- 8.35
- EV/EBITDA
- -50.20
- Div Yield
- 0.00%
- Gross Margin
- 74.75%
- Op Margin
- -15.92%
- Net Margin
- -21.33%
- ROE
- -35.44%
- ROIC
- -16.77%
- Revenue
- $256.18M · 18.39%
- Net Income
- $-54,639,000 · 5.03%
- EPS
- $-0.66 · 5.71%
- Op Income
- $-40,778,000
- FCF YoY
- 52.03%
- 52W High
- $13.13
- 52W Low
- $4.65
- 50D MA
- $13.03
- 200D MA
- $9.71
- Beta
- 1.47
- Avg Volume
- 2.57M
Get TickerSpark's AI analysis on FNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 21, 25 | McCormack Robert S | sell | 203,134 |
| Apr 21, 25 | McCormack Robert S | sell | 20,014 |
| Apr 21, 25 | Scanlon Meghan | sell | 42,113 |
| Apr 21, 25 | SCHNETTLER THOMAS P | sell | 45,035 |
| Apr 21, 25 | Oesterle Stephen N. | sell | 250,000 |
| Apr 21, 25 | Oesterle Stephen N. | sell | 40,216 |
| Apr 21, 25 | JOHNSON B KRISTINE | sell | 47,347 |
| Apr 21, 25 | Jarboe Matthew | sell | 575,320 |
| Apr 21, 25 | Jarboe Matthew | sell | 27,588 |
| Apr 21, 25 | Jarboe Matthew | sell | 50,000 |
Our FNA coverage
Recent articles, reports, and earnings notes.
No research on FNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FNA report →Similar companies
Peers in the same neighborhood.